Oral Antibiotics Market - Global Industry Analysis

Oral Antibiotics Market

Oral Antibiotics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6326 Status : Upcoming

Description

Global Oral Antibiotics Market: Overview

Antibiotics are antimicrobial compound that effectively fights against protozoan and bacterial infections but not viral infections. These medications halt the growth of bacteria from spreading further and also kill the bactericidal antibiotics. There are different types of antibiotics available at pharma stores & hospitals and are sold with & without prescription in many countries. Antibiotics are majorly utilized during joint replacement, suppress the immune system, dialysis, and transplant.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Oral Antibiotics Market: Growth Factors

The growing prevalence of several diseases like tuberculosis, malaria, pneumonia, and lower respiratory infections all across the globe is increasing the burden on healthcare infrastructures. Hence, such a rapidly increasing prevalence of bacterial and infectious diseases all across the globe is one of the major factors driving the growth of the global oral antibiotics market vigorously. Pharmaceutical companies are making several efforts to develop novel therapies that can effectively treat infectious diseases. Also, the growing government initiatives to expedite the approval process and commercialize the drugs are supporting the pharmaceutical companies to launch innovative antibiotic drugs rapidly into the market. There is significant growth in investments along with research & development activities by prominent market players for developing effective antibiotics drugs. Moreover, several pharmaceutical manufacturers are collaborating in order to reduce the burden of the high cost involved in the drug development process. However, such emerging scenarios are significantly escalating the growth of the global oral antibiotics market during the forecast period. Also, the outbreak of coronavirus has significantly boosted the demand for antibiotics to treat the several complications caused by the Covid-19 virus.

Global Oral Antibiotics Market: Segmentation

The global oral antibiotics market can be segmented into drug type, the spectrum of activity, drug origin, application, class, and region.

By drug type, the market can be segmented into generic and branded.

By spectrum of activity, the market can be segmented into narrow and broad-spectrum antibiotics.

By drug origin, the market can be segmented into synthetic, semisynthetic, and natural. The synthetic segment accounts for the largest share in the global oral antibiotics market due to the surging need for synthetic membrane-targeted antibiotics owing to the fact that they are antimicrobial resistant. Such synthetic antibiotics include several other advantages like no cross-resistance with the other antibiotics, a broad spectrum of activity, and a low probability of developing resistance.

By application, the market can be segmented into dental, urinary acquired tract infection, community respiratory tract infections, and others. The urinary acquired tract infection segment holds hegemony over others.

By class, the market can be segmented into macrolide, quinolone, and beta-lactam & beta-lactamase inhibitors. The beta-lactam & beta-lactamase inhibitors segment holds the largest share in the global oral antibiotics market due to its broad range of activities. It is effective against both gram-positive and gram-negative bacteria along with several other groups of bacterial infections.

Global Oral Antibiotics Market: Regional analysis

Asia Pacific accounts for the largest share in the global oral antibiotics market due to the high consumption of antibiotics along with the increasing prevalence of infectious diseases in the region. Moreover, the growing government initiatives to launch novel therapies to treat the various infections effectively will further propel the growth of the regional market during the forecast period.

North America accounts for the second largest share in the global oral antibiotics market due to the presence of well-developed healthcare infrastructure in the region. The growing research and development activities in the region to develop effective drugs against virus infection will also boost the growth of the regional market during the forecast period.

Global Oral Antibiotics Market: Competitive Players

Some of the significant players in the global oral antibiotics market are Sun Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., Novartis AG, Merck KGaA, MELINTA THERAPEUTICS, INC., Mayne Pharma Group Ltd., Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Bristol Myers Squibb Company, Bayer AG, AstraZeneca Plc, Astellas Pharma, and Abbott Laboratories.

Global Oral Antibiotics Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

The growing prevalence of several diseases like tuberculosis, malaria, pneumonia, and lower respiratory infections all across the globe is increasing the burden on healthcare infrastructures. Hence, such a rapidly increasing prevalence of bacterial and infectious diseases all across the globe is one of the major factors driving the growth of the global oral antibiotics market vigorously during the forecast period.

Some of the significant players in the global oral antibiotics market are Sun Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., Novartis AG, Merck KGaA, MELINTA THERAPEUTICS, INC., Mayne Pharma Group Ltd., Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Inc.

Asia Pacific accounts for the largest share in the global oral antibiotics market due to the high consumption of antibiotics along with the increasing prevalence of infectious diseases in the region. Moreover, the growing government initiatives to launch novel therapies to treat the various infections effectively further propel the growth of the regional market during the forecast period.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed